
Opinion|Videos|April 4, 2024
Real-World Data Surrounding Sequencing Strategies for Refractory mCRC
Multiple abstracts from ESMO 2023, including a focus on tumor location, are highlighted.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Orca-T for Matched Donor HSCT in Hematologic Malignancies
2
As ADC Options Expand, Sequencing and Toxicity Management Become the Next Challenges in Gynecologic Oncology
3
Epcoritamab Plus Lenalidomide Improves PFS vs R-GemOx in R/R DLBCL
4
MANGROVE Trial Shows Improved Efficacy With Zanubrutinib Plus Rituximab vs Chemo in MCL
5























































































